|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss and comprehensive loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Accretion of discount on note payable | |||||
| Amortization of debt issue costs | |||||
| Loss on debt extinguishment | |||||
| Issuance cost and change in fair value of derivative | |||||
| Changes in operating assets and liabilities: | |||||
| Miscellaneous receivables | |||||
| Prepaid expenses and other current assets | |||||
| Operating lease right-of-use assets | |||||
| Trade accounts payable and accrued expenses | |||||
| Current portion of operating lease liability | |||||
| Long-term portion of operating lease liability | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Financing Activities: | |||||
| Proceeds from the issuance of common stock and pre-funded common stock purchase warrants, net of fees | |||||
| Proceeds from notes payable | |||||
| Principal payments on finance lease obligations | |||||
| Net cash provided by financing activities | |||||
| Cash and cash equivalents: | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Non-cash activities | |||||
| Property and equipment accrued but not paid at end of year | |||||
| Cash payments: | |||||
| Interest paid | |||||
Loading...